156 related articles for article (PubMed ID: 10619498)
1. High dose chemotherapy with autologous stem cell rescue in adults with malignant primary brain tumors.
Abrey LE; Rosenblum MK; Papadopoulos E; Childs BH; Finlay JL
J Neurooncol; 1999 Sep; 44(2):147-53. PubMed ID: 10619498
[TBL] [Abstract][Full Text] [Related]
2. High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors.
Shih CS; Hale GA; Gronewold L; Tong X; Laningham FH; Gilger EA; Srivastava DK; Kun LE; Gajjar A; Fouladi M
Cancer; 2008 Mar; 112(6):1345-53. PubMed ID: 18224664
[TBL] [Abstract][Full Text] [Related]
3. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
[TBL] [Abstract][Full Text] [Related]
4. Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma.
Sung KW; Lee SH; Yoo KH; Jung HL; Cho EJ; Koo HH; Lee SK; Kim J; Lim DH; Suh YL; Kim DW
Bone Marrow Transplant; 2007 Jul; 40(1):37-45. PubMed ID: 17468771
[TBL] [Abstract][Full Text] [Related]
5. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.
Graham ML; Herndon JE; Casey JR; Chaffee S; Ciocci GH; Krischer JP; Kurtzberg J; Laughlin MJ; Longee DC; Olson JF; Paleologus N; Pennington CN; Friedman HS
J Clin Oncol; 1997 May; 15(5):1814-23. PubMed ID: 9164190
[TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
[TBL] [Abstract][Full Text] [Related]
8. High-dose Chemotherapy With Autologous Stem Cell Rescue in Saudi Children Less Than 3 Years of Age With Embryonal Brain Tumors.
Alsultan A; Alharbi M; Al-Dandan S; Bayoumi Y; Alharbi T; Alsudairy R; Alomari A; Aljamaan K; Musleh O; Alharbi Q; Jarrar M
J Pediatr Hematol Oncol; 2015 Apr; 37(3):204-8. PubMed ID: 25551668
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor.
Laurence V; Pierga JY; Barthier S; Babinet A; Alapetite C; Palangié T; de Pinieux G; Anract P; Pouillart P
Am J Clin Oncol; 2005 Jun; 28(3):301-9. PubMed ID: 15923805
[TBL] [Abstract][Full Text] [Related]
10. Successive double high-dose chemotherapy with peripheral blood stem cell rescue collected during a single leukapheresis round in patients with high-risk pediatric solid tumors: a pilot study in a single center.
Sung KW; Yoo KH; Chung EH; Jung HL; Koo HH; Shin HJ; Lee SK; Lim DH; Kim DW; Park HK; Cho EJ; Kim SW
Bone Marrow Transplant; 2003 Mar; 31(6):447-52. PubMed ID: 12665839
[TBL] [Abstract][Full Text] [Related]
11. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
Modak S; Gardner S; Dunkel IJ; Balmaceda C; Rosenblum MK; Miller DC; Halpern S; Finlay JL
J Clin Oncol; 2004 May; 22(10):1934-43. PubMed ID: 15143087
[TBL] [Abstract][Full Text] [Related]
12. Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group.
Finlay JL; Dhall G; Boyett JM; Dunkel IJ; Gardner SL; Goldman S; Yates AJ; Rosenblum MK; Stanley P; Zimmerman RA; Wallace D; Pollack IF; Packer RJ;
Pediatr Blood Cancer; 2008 Dec; 51(6):806-11. PubMed ID: 18802947
[TBL] [Abstract][Full Text] [Related]
13. [High-dose chemotherapy with autologous stem cell rescue in children with high-risk and recurrent brain tumors].
Pérez Martínez A; Quintero Calcaño V; González Vicent M; Contra Gómez T; Díaz Pérez MA; Madero López L; Sevilla Navarro J
An Pediatr (Barc); 2004 Jul; 61(1):8-15. PubMed ID: 15228928
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
Pérez-Martínez A; Lassaletta A; González-Vicent M; Sevilla J; Díaz MA; Madero L
J Neurooncol; 2005 Jan; 71(1):33-8. PubMed ID: 15719272
[TBL] [Abstract][Full Text] [Related]
15. A study of sequential high dose cyclophosphamide and high dose carboplatin with peripheral stem-cell rescue in resistant or recurrent pediatric brain tumors.
Foreman NK; Schissel D; Le T; Strain J; Fleitz J; Quinones R; Giller R
J Neurooncol; 2005 Jan; 71(2):181-7. PubMed ID: 15690136
[TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy with autologous stem cell rescue for brain tumors.
Dunkel IJ; Finlay JL
Crit Rev Oncol Hematol; 2002 Feb; 41(2):197-204. PubMed ID: 11856595
[TBL] [Abstract][Full Text] [Related]
17. Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group.
Cohen BH; Geyer JR; Miller DC; Curran JG; Zhou T; Holmes E; Ingles SA; Dunkel IJ; Hilden J; Packer RJ; Pollack IF; Gajjar A; Finlay JL;
Pediatr Neurol; 2015 Jul; 53(1):31-46. PubMed ID: 26092413
[TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy followed by autologous stem cell rescue in Wilms tumors: French report on toxicity and efficacy.
Delafoy M; Verschuur A; Scheleirmacher G; Tabone MD; Sudour-Bonnange H; Thébaud E; Freycon C; Notz-Carrère A; Boulanger C; Pellier I; Irtan S; Muracciole X; Coulomb-L'Hermine A; Dijoud F; Morelle M; Bergeron C; Pasqualini C
Pediatr Blood Cancer; 2022 Mar; 69(3):e29431. PubMed ID: 34811873
[TBL] [Abstract][Full Text] [Related]
19. High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.
Papadopoulos KP; Garvin JH; Fetell M; Vahdat LT; Garrett TJ; Savage DG; Balmaceda C; Bruce J; Sisti M; Isaacson S; De LaPaz R; Hawks R; Bagiella E; Antman KH; Hesdorffer CS
Bone Marrow Transplant; 1998 Oct; 22(7):661-7. PubMed ID: 9818693
[TBL] [Abstract][Full Text] [Related]
20. Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma.
Zia MI; Forsyth P; Chaudhry A; Russell J; Stewart DA
Bone Marrow Transplant; 2002 Nov; 30(9):565-9. PubMed ID: 12407430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
